Life-threatening infection in transplant recipients

Crit Care Clin. 2013 Oct;29(4):953-73. doi: 10.1016/j.ccc.2013.06.012. Epub 2013 Aug 8.

Abstract

Modern post-transplant care pathways commonly encompass periods of critical care support. Infectious events account for many of these interactions making critical care physicians integral members of multidisciplinary transplant teams. Despite continuing advances in clinical care and infection prophylaxis, the morbidity and mortality attributable to infection post-transplant remains considerable. Emerging entities constantly add to the breadth of potential opportunistic pathogens. Individualized risk assessments, rapid and thorough diagnostic evaluation, and prompt initiation of appropriate antimicrobial therapies are essential. The approach to managing transplant recipients with infection in critical care is discussed and common and emerging opportunistic pathogens are reviewed.

Keywords: Critical care; Immunosuppression; Microbiological diagnosis; Opportunistic infection; Transplant infection.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Infective Agents / therapeutic use
  • Critical Care / methods
  • Cross Infection / diagnosis
  • Cross Infection / drug therapy*
  • Cross Infection / microbiology
  • Humans
  • Immunocompromised Host*
  • Immunosuppressive Agents / adverse effects*
  • Immunosuppressive Agents / pharmacology
  • Opportunistic Infections / diagnosis
  • Opportunistic Infections / drug therapy*
  • Postoperative Complications / drug therapy*
  • Postoperative Complications / immunology
  • Transplantation*

Substances

  • Anti-Infective Agents
  • Immunosuppressive Agents